Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Real-time Estimate Cboe BZX
Other stock markets
 10:57:38 2024-06-10 am EDT 		5-day change 1st Jan Change
0.258 USD +0.23% Intraday chart for GlycoMimetics, Inc. -5.52% -89.04%
Jun. 04 Transcript : GlycoMimetics, Inc. - Special Call
Jun. 04 GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia CI

Evolution of the average Target Price on GlycoMimetics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

98f99c22952b287f6.MGZSN85lw7hixyvDgBEgxyc0SrPlc99LPMnY38DE9Yg.fzwKcpY9qNQnt0Og41Vzn158LPHVIqYjUoGJ8omIr-QFMCd_9zqp6lWjZg~b5101b2279b3d68a3bf4303fe7c2f7bc

Analyst Recommendations on GlycoMimetics, Inc.

Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 MT
Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12 MT
HC Wainwright Adjusts GlycoMimetics Price Target to $13 From $14, Maintains Buy Rating MT
Jefferies Raises GlycoMimetics to Buy From Hold, Price Target to $4 From $3 MT
GLYCOMIMETICS : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.2574 USD
Average target price
0.75 USD
Spread / Average Target
+191.38%
High Price Target
1 USD
Spread / Highest target
+288.50%
Low Price Target
0.5 USD
Spread / Lowest Target
+94.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GlycoMimetics, Inc.

Capital One Securities
HC Wainwright
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Consensus GlycoMimetics, Inc.